Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Cynara Scolymus, Solidago Virgaurea, Taraxacum Officinale, Benzoicum Acidum, Berberis Vulgaris, Bryonia, Cantharis, Carduus Benedictus, Carduus Marianus, Ceanothus Americanus, Chelidonium Majus, Chionanthus Virginica, Cinchona Officinalis, Dioscorea Villosa, Dolichos Pruriens, Iris Versicolor, Juniperus Communis, Nux Vomica, Ptelea Trifoliata, Taraxacum Officinale, Uricum.
Brand Name
Drainer
Generic Name
Cynara Scolymus, Solidago Virgaurea, Taraxacum Officinale, Benzoicum Acidum, Berberis Vulgaris, Bryonia, Cantharis, Carduus Benedictus, Carduus Marianus, Ceanothus Americanus, Chelidonium Majus, Chionanthus Virginica, Cinchona Officinalis, Dioscorea Villosa, Dolichos Pruriens, Iris Versicolor, Juniperus Communis, Nux Vomica, Ptelea Trifoliata, Taraxacum Officinale, Uricum.
Active Ingredient
Benzoic AcidCategory
Nitrogen Binding Agent [EPC]
Variants
2
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 15 [hp_X]/g | PELLET | ORAL | 55714-4793 |
| 15 [hp_X]/mL | LIQUID | ORAL | 55714-4792 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Drainer, you must consult a qualified healthcare professional.
Detailed information about Drainer
Benzoic Acid is a multifaceted compound used clinically as a nitrogen binding agent for hyperammonemia and topically as an antifungal. It belongs to the Nitrogen Binding Agent [EPC] class and is a critical component in the management of urea cycle disorders.
Dosage of Benzoic Acid must be highly individualized, particularly when used for nitrogen binding.
Pediatric dosing is critical and must be calculated based on body surface area (BSA) or weight to avoid toxicity.
Benzoic Acid and its metabolite, hippuric acid, are primarily excreted by the kidneys. In patients with significant renal impairment (GFR < 30 mL/min), the clearance of hippuric acid is reduced, which may lead to metabolic acidosis and increased systemic toxicity. Healthcare providers may reduce the dose by 25% to 50% and monitor blood pH and ammonia levels more frequently.
Since the conjugation of Benzoic Acid with glycine occurs primarily in the liver, patients with hepatic insufficiency may have a reduced capacity to form hippuric acid. This can lead to an accumulation of unconjugated Benzoic Acid. Dosing should be initiated at the lower end of the spectrum, and liver function tests (LFTs) should be monitored.
Geriatric patients often have age-related declines in renal function. Dosing should be conservative, starting at the lower end of the adult range, with careful monitoring of electrolyte balance and renal markers.
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the regular schedule. Do not double the dose to catch up, as this increases the risk of metabolic acidosis.
Signs of Benzoic Acid overdose include:
In case of suspected overdose, contact a poison control center or emergency services immediately. Emergency treatment often involves intravenous fluids, bicarbonate therapy to correct acidosis, and in severe cases, hemodialysis to remove benzoate and hippuric acid from the blood.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as ammonia levels can rise rapidly and dangerously.
Patients taking systemic Benzoic Acid (Sodium Benzoate) frequently report gastrointestinal and metabolic symptoms:
Benzoic Acid is a potent pharmacological agent that requires strict medical supervision. It is not a 'simple' preservative when used at therapeutic doses. Patients and caregivers must be aware that Benzoic Acid does not cure urea cycle disorders; it only helps manage the symptoms by removing excess nitrogen. If the underlying cause of hyperammonemia is not addressed (e.g., through diet or other medications), ammonia can still reach toxic levels.
No FDA black box warnings for Benzoic Acid as a standalone ingredient. However, clinicians must adhere to the warnings associated with branded nitrogen scavengers, which emphasize the risk of over-dosage leading to metabolic acidosis and the critical need for specialized center management.
Benzoic Acid must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Benzoic Acid in pregnant women. Animal reproduction studies have shown some evidence of fetal harm at very high doses.
It is not known whether Benzoic Acid is excreted in human milk. However, because many drugs are excreted in milk and because of the potential for serious adverse reactions in nursing infants (such as metabolic acidosis), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Benzoic Acid acts as a pro-drug for nitrogen excretion. The molecular mechanism involves two steps:
This pathway is significant because it provides a 'bypass' for the urea cycle. Under normal conditions, nitrogen is removed via the synthesis of urea. In patients with urea cycle defects, this pathway is blocked. By forming hippuric acid, the body can 'package' nitrogen (as part of the glycine molecule) and excrete it via the kidneys. One mole of Benzoic Acid removes one mole of nitrogen.
Common questions about Drainer
Benzoic Acid is primarily used in two ways: as a systemic treatment for urea cycle disorders and as a topical antifungal. When taken as a medication (often as sodium benzoate), it helps the body remove toxic ammonia by binding to nitrogen and allowing it to be excreted in the urine. This is life-saving for patients whose bodies cannot process nitrogen through the normal urea cycle. Topically, it is used in Whitfield's Ointment to treat fungal skin infections like athlete's foot. Additionally, it is one of the most common preservatives used in the food and pharmaceutical industries to prevent the growth of bacteria and mold.
The most common side effects of Benzoic Acid, particularly when taken orally in high doses for metabolic disorders, include gastrointestinal distress such as nausea, vomiting, and a loss of appetite. These symptoms are often due to the medication's salty taste and its irritating effect on the stomach lining. When used topically on the skin, it may cause temporary stinging, redness, or mild irritation at the application site. Some patients may also experience headaches or a general feeling of tiredness. It is important to monitor these symptoms, as severe nausea or vomiting can sometimes be a sign that the medication is affecting your blood's acid balance.
No, you should generally avoid drinking alcohol while taking therapeutic doses of Benzoic Acid. Alcohol can place additional stress on the liver, which is the primary organ responsible for processing Benzoic Acid into its excretable form, hippuric acid. Furthermore, alcohol consumption can interfere with the management of the underlying conditions for which Benzoic Acid is prescribed, such as urea cycle disorders. Alcohol can also worsen the stomach irritation and nausea that many patients experience with this medication. Always consult your healthcare provider about your lifestyle and any substances you consume while on this treatment.
Benzoic Acid is classified as FDA Pregnancy Category C, meaning its safety has not been fully established through human clinical trials. While it is not known to cause birth defects at standard doses, there is a theoretical risk that high levels of benzoates in the mother's blood could affect the baby, particularly near the time of delivery. In pregnant women with urea cycle disorders, the risk of untreated high ammonia levels is often much more dangerous to both the mother and the fetus than the medication itself. Therefore, doctors may prescribe it if the benefits clearly outweigh the risks. Pregnant women should be monitored closely by a specialist in metabolic medicine.
When administered intravenously for acute hyperammonemia, Benzoic Acid begins to lower ammonia levels within 1 to 2 hours. For chronic oral use, it works continuously as long as it is taken on a regular schedule to prevent ammonia from building up. In its topical form for fungal infections, it may take several days to a week of consistent use before a visible improvement in the skin is noticed. For antifungal treatment, it is crucial to complete the full course prescribed by your doctor, even if the symptoms seem to disappear early, to prevent the infection from returning.
You should never stop taking Benzoic Acid suddenly if you are using it to manage a urea cycle disorder. Stopping the medication can cause a rapid and dangerous rise in blood ammonia levels, which can lead to brain swelling, seizures, coma, or even death. If you are experiencing side effects that make it difficult to take the medication, contact your doctor immediately so they can adjust your treatment plan safely. Any changes to the dosage or discontinuation of the drug must be managed by a healthcare professional, usually with close monitoring of your blood chemistry.
If you miss a dose of Benzoic Acid, take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and simply take the next one at the regular time. Do not take two doses at once to make up for the missed one, as this can increase the risk of metabolic acidosis (too much acid in the blood). For patients with urea cycle disorders, missing multiple doses can be a medical emergency, so it is helpful to use a pill organizer or alarm to stay on schedule. If you miss more than one dose, contact your doctor for advice.
Benzoic Acid itself is not known to cause weight gain. In fact, many patients taking high doses for metabolic disorders may experience weight loss or difficulty gaining weight due to side effects like nausea and a decreased appetite. Furthermore, patients using this medication are often on a strict, low-protein diet, which can make it challenging to consume enough calories. In pediatric patients, doctors monitor weight and growth very closely to ensure the child is receiving adequate nutrition while on the medication. If you notice unexpected weight changes, discuss them with your healthcare provider or a specialized dietitian.
Benzoic Acid can interact with several other medications, so it is vital to provide your doctor with a complete list of everything you take. Specifically, medications like Probenecid (for gout) and certain antibiotics can slow down the removal of Benzoic Acid from your body, potentially leading to toxicity. Aspirin and other salicylates can also interfere with how the drug is processed. Additionally, medications that increase ammonia levels, such as Valproic Acid, should be avoided. Your doctor will carefully check for these interactions to ensure that Benzoic Acid is both safe and effective for you.
Yes, Benzoic Acid is available in several generic forms, particularly as its salt, sodium benzoate. It is also found in generic combination products for topical use (like Benzoic and Salicylic Acid ointment). The intravenous form used for emergencies is also available as a generic version of the brand Ammonul. Generic versions are typically more cost-effective than brand-name medications and are required by the FDA to have the same quality, strength, and purity. Your pharmacist or insurance provider can help you determine which version is most appropriate and affordable for your specific needs.
Other drugs with the same active ingredient (Benzoic Acid)
> Warning: Stop taking Benzoic Acid and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of Benzoic Acid, especially in the management of urea cycle disorders, requires monitoring for:
There are currently no formal FDA Black Box Warnings specifically for Benzoic Acid as a single agent; however, the combination product Ammonul (Sodium Benzoate/Sodium Phenylacetate) carries significant warnings regarding the risk of Acute Ammonia Toxicity if the infusion is not managed correctly, and the risk of Neurotoxicity if dosage limits are exceeded. Healthcare providers must ensure that the patient's ammonia levels are monitored hourly during acute treatment.
Report any unusual symptoms or changes in mental status to your healthcare provider immediately. Regular blood tests are necessary to ensure the medication is working safely.
Patients on Benzoic Acid therapy require frequent laboratory monitoring to ensure safety and efficacy:
Benzoic Acid may cause dizziness, lethargy, or confusion in some patients. Patients should not drive or operate heavy machinery until they know how the medication affects them. If confusion or disorientation occurs, it may be a sign of high ammonia or medication toxicity, and medical help should be sought.
Alcohol should be avoided while taking Benzoic Acid. Alcohol can stress the liver's metabolic capacity and may interfere with the conjugation process. Furthermore, alcohol can exacerbate the gastrointestinal side effects of the medication.
Benzoic Acid should never be stopped suddenly in patients with urea cycle disorders. Sudden discontinuation can lead to a rapid and potentially fatal 'rebound' increase in ammonia levels (hyperammonemic crisis). If the medication must be stopped, it should only be done under the direct supervision of a metabolic specialist, usually in a hospital setting.
> Important: Discuss all your medical conditions, including any history of heart, kidney, or liver disease, with your healthcare provider before starting Benzoic Acid.
For each major interaction, the mechanism typically involves either competitive inhibition of renal secretion or metabolic competition for glycine. The clinical consequence is usually an increased risk of Benzoic Acid toxicity (acidosis) or a decrease in the efficacy of nitrogen scavenging (rising ammonia).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers and cold medications.
Patients who are allergic to the following substances may also react to Benzoic Acid:
> Important: Your healthcare provider will evaluate your complete medical history, including any allergies and your kidney and heart function, before prescribing Benzoic Acid.
Benzoic Acid is widely used in pediatric populations for the management of urea cycle disorders. However, it is associated with significant risks in the very young:
Clinical studies of Benzoic Acid did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
In patients with impaired renal function, the clearance of hippuric acid is significantly reduced.
Since the liver is the primary site of glycine conjugation, patients with hepatic impairment (Child-Pugh Class B or C) may experience higher levels of unconjugated Benzoic Acid. This increases the risk of CNS toxicity and acidosis. Frequent monitoring of liver enzymes and plasma benzoate levels (if available) is recommended.
> Important: Special populations require individualized medical assessment and often require management by a team of specialists, including geneticists, hepatologists, and neonatologists.
| Parameter | Value |
|---|---|
| Bioavailability | >90% (Oral) |
| Protein Binding | 70% - 90% (Primarily Albumin) |
| Half-life | 2 - 4 hours (Normal function) |
| Tmax | 1 - 2 hours |
| Metabolism | Hepatic/Renal Glycine Conjugation |
| Excretion | Renal (>95% as Hippuric Acid) |
Benzoic Acid is primarily classified as a Nitrogen Binding Agent [EPC]. It is also grouped with Antifungals (topical) and Pharmaceutical Preservatives. Related medications in the nitrogen binding class include Sodium Phenylbutyrate and Glycerol Phenylbutyrate, which follow a similar 'scavenging' logic but utilize a different amino acid (glutamine) for excretion.